Cargando…
Serum Levels of Tumor Necrosis Factor-α and Vascular Endothelial Growth Factor in the Subtypes of Clinical High Risk Individuals: A Prospective Cohort Study [Letter]
Autores principales: | Lienggonegoro, Lisa Andriani, Dany, Frans, Panjaitan, Novaria Sari Dewi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479559/ https://www.ncbi.nlm.nih.gov/pubmed/37675186 http://dx.doi.org/10.2147/NDT.S435561 |
Ejemplares similares
-
Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2022) -
Response to Article “Autophagy Inhibits Inflammation via Down-Regulation of p38 MAPK/mTOR Signaling Cascade in Endothelial Cells” [Letter]
por: Maha, Masri Sembiring, et al.
Publicado: (2023) -
A Response to Article Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year after Standard Treatment [Letter]
por: Panjaitan, Novaria Sari Dewi
Publicado: (2022) -
Critical Response to Article “Integrated Network Pharmacology and Experimental Validation Approach to Investigate the Mechanisms of Stigmasterol in the Treatment of Rheumatoid Arthritis” [Letter]
por: Rinendyaputri, Ratih, et al.
Publicado: (2023) -
A Response to Research Article “Cefmetazole Resistance Mechanism for Escherichia Coli Including ESBL-Producing Strains” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2022)